Poly Medicure Quarterly Results for Trading Insights

POLYMED • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹92 Cr
QSept 2025
Quarterly Results

Poly Medicure Quarterly Results Key Highlights

  • Revenue of ₹479 Cr in Sept 2025 (+2.6% vs Mar 2025, +7.2% vs Sept 2024)
  • Net Profit of ₹92 Cr in Sept 2025 (+0.0% vs Mar 2025, +5.7% vs Sept 2024)
  • EBITDA of ₹150 Cr in Sept 2025 (+2.7% vs Mar 2025)
  • Operating Margin of 26.0% in Sept 2025 (-1.0pp vs Mar 2025)
  • Earnings Per Share of ₹9.06 in Sept 2025 (+1.6% vs Mar 2025)

Poly Medicure Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 479 467 447 522 447 2.6% 7.2%
Net Profit (₹ Cr) 92 92 93 71 87 - -
EBITDA (₹ Cr) 150 146 149 132 142 - -
EPS (₹) 9.06 8.92 9.19 7.00 9.01 - -
Operating Margin (%) 26.0% 27.0% 26.0% 21.0% 27.0% - -

Poly Medicure Share Price Trend Around Quarterly Results

Visualize Poly Medicure's 1-year price movement across quarterly results — ideal for logging trades in Poly Medicure share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 19.2%
EBITDA Margin 31.3%
Operating Margin 26.0%
ROE (Annual) 13.3%

Balance Sheet Highlights

Total Assets ₹3,193 Cr
Total Equity ₹2,766 Cr
Current Assets ₹1,917 Cr
Current Liabilities ₹57 Cr

Cash Flow Analysis

Operating Cash Flow ₹240 Cr
Investing Cash Flow ₹-1,194 Cr
Financing Cash Flow ₹951 Cr
Net Cash Flow ₹-3 Cr

Current Market Data

Current Price ₹1314.00
Exchange NSE
Last Updated Mar 02, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Poly Medicure quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹416,764.48 Cr 1752.5 14,875 3,125 +10.8% - 21.0% 134.8
Divis Laboratories
Sept 2025
₹170,125.54 Cr 6403.5 2,860 689 +7.1% - 24.1% 246.6
Torrent Pharmaceuti…
Sept 2025
₹146,658.56 Cr 4369.2 3,219 591 +11.3% - 18.4% 249.1
Cipla
Sept 2025
₹109,178.44 Cr 1351.6 7,716 1,353 +12.0% - 17.5% 80.8
Dr Reddys Laborator…
Sept 2025
₹107,358.50 Cr 1294.4 9,135 1,337 +1.1% - 14.6% 80.0
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores